Translation of triple-negative breast cancer behavior from xenograft model to human
Abstract:
Background
For xenograft models of triple-negative breast cancer (TNBC) to be valuable in development of molecularly-targeted drugs, careful characterization is essential to their validation. The present study aimed to validate the TNBC xenograft model with a specific focus on angiogenesis.
Methods
Twelve TNBC xenograft tumors and 12 human breast cancer tumors (HTNBC) were included in this study. Both groups were grade III and p53 positive. Nuclear pleomorphism and mitotic count were analyzed by hematoxylin and eosin (H&E) stains respectively. Basal cytokeratin (CK5/6), vimentin, cathepsin-D, Ki-67 (for proliferation), and MVD-CD34 (for angiogenesis) markers were examined by immunohistochemistry (IHC). The association of Microvesseles density (MVD) with Ki-67, nuclear pleomorphism, and mitotic count was assessed in each group separately, and HTNBCs were compared with the xenograft group.
Results
The xenograft models showed a significant correlation between angiogenesis (MVD) and cell proliferation (Ki-67), nuclear pleomorphism, and mitotic count (p= 0.0398; p= 0.020; p=0.001, respectively). The HTNBC group also showed a similar trend, except nuclear pleomorphism (p=0.193), which did not correlate with angiogenesis. Comparison between the two groups showed significant changes in cell proliferation (Ki-67 and vimentin). The difference in proliferation rate and vimentin expression between the two groups can be due to biological diversity between human and mice and epithelial-mesenchymal transition (EMT), respectively.
Conclusion
Our results, re-emphasize the significance of angiogenic treatment therapy in patients with TNBC, and further validate the TNBC xenograft model as a valid model for drug discovery and development.
Language:
English
Published:
Basic and Clinical Cancer Research, Volume:8 Issue: 3, Summer 2016
Pages:
9 to 16
magiran.com/p1612435  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 990,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
دسترسی سراسری کاربران دانشگاه پیام نور!
اعضای هیئت علمی و دانشجویان دانشگاه پیام نور در سراسر کشور، در صورت ثبت نام با ایمیل دانشگاهی، تا پایان فروردین ماه 1403 به مقالات سایت دسترسی خواهند داشت!
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 50 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!